A body of evidence indicates that epigenetic changes including a reduction in heterochromatin are associated with aging (Pal & Tyler, 2016; Zane, Sharma, & Misteli, 2014), and disrupting the Ran gradient in cancer cells can promote senescence (Cekan et al., 2016). The gene discussed is RAN; the disease is cancer.